Finance

Lists
AGN:ASX
Argenica Therapeutics Ltd
A$0.20
+2.56%
(+0.0050) 1D
Aug 28, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AGN...
Open
A$0.20
High
A$0.20
Low
A$0.19
Mkt. cap
25.69M
Avg. vol.
140.87K
Volume
86.15K
52-wk high
A$0.68
52-wk low
A$0.09
EPS
-A$0.08
Shares outstanding
128.46M
Open
A$0.20
High
A$0.20
Low
A$0.19
Mkt. cap
25.69M
Avg. vol.
140.87K
Volume
86.15K
52-wk high
A$0.68
52-wk low
A$0.09
EPS
-A$0.08
Shares outstanding
128.46M
About Argenica Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Last report
Jul 23, 2026
Fiscal period
Q4 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
2.53M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
313.37K
313.37K
2.53M
2.53M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.52M
1.52M
-
588.41K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
739.40K
739.40K
670.01K
670.01K
Operating expense
2.27M
2.27M
-
-
Total operating expenses
2.27M
2.27M
1.26M
1.26M
Operating income
-1.96M
-1.96M
1.27M
1.27M
Other non operating income
-
-
-
-
EBT including unusual items
-1.91M
-1.91M
1.23M
1.23M
EBT excluding unusual items
-1.91M
-1.91M
1.23M
1.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.91M
-1.91M
1.23M
-
Net profit margin
-609.00%
-609.00%
48.35%
48.35%
Earnings per share
-
-
-
-
Interest and investment income
46.72K
46.72K
-
-
Interest expense
-94.00
-94.00
-46.78K
-
Net interest expenses
46.62K
46.62K
-46.78K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps